These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 11440557

  • 21. Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
    Cazzola M, Mantero A, Santus P, Carlucci P, Mondoni M, Bosotti L, Centanni S.
    Pulm Pharmacol Ther; 2007; 20(3):258-64. PubMed ID: 16600647
    [Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A.
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [Abstract] [Full Text] [Related]

  • 23. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
    Aalbers R, Brusselle G, McIver T, Grothe B, Bodzenta-Lukaszyk A.
    Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745
    [Abstract] [Full Text] [Related]

  • 24. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ, Allen D, McDonnell B, Wheeler N, Sharma RK, Sykes A, Woodcock A.
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [Abstract] [Full Text] [Related]

  • 25. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N, Ohnishi H, Fujita J, Kamei T, Tada S, Ueda N.
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
    Raissy HH, Harkins M, Esparham A, Kelly HW.
    Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
    [Abstract] [Full Text] [Related]

  • 27. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
    Roux FJ, Grandordy B, Douglas JS.
    Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
    [Abstract] [Full Text] [Related]

  • 28. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J, Ankerst J.
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [Abstract] [Full Text] [Related]

  • 29. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
    Jeppsson AB, Nilsson E, Waldeck B.
    Eur J Pharmacol; 1994 May 12; 257(1-2):137-43. PubMed ID: 8082695
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS, Perin C, Pelegrin L, Fernandes JC, da Silva LC.
    J Bras Pneumol; 2006 May 12; 32(3):202-6. PubMed ID: 17273608
    [Abstract] [Full Text] [Related]

  • 31. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S, Hancox RJ.
    Respir Med; 2005 May 12; 99(5):566-71. PubMed ID: 15823453
    [Abstract] [Full Text] [Related]

  • 32. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
    Clin Ther; 2007 Feb 12; 29(2):261-78. PubMed ID: 17472819
    [Abstract] [Full Text] [Related]

  • 33. The effects of bronchodilators on spontaneous ventilation and oxygen consumption in rhesus monkeys.
    Newth CJ, Amsler B, Richardson BP, Hammer J.
    Pediatr Res; 1997 Aug 12; 42(2):157-62. PubMed ID: 9262216
    [Abstract] [Full Text] [Related]

  • 34. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May 12; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 35. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun 12; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 36. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
    Ramsdale EH, Otis J, Kline PA, Gontovnick LS, Hargreave FE, O'Byrne PM.
    Am Rev Respir Dis; 1991 May 12; 143(5 Pt 1):998-1001. PubMed ID: 1673830
    [Abstract] [Full Text] [Related]

  • 37. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 38. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ, Hall IP, Aziz I, Tan KS, Wheatley A.
    Clin Sci (Lond); 1999 Mar 22; 96(3):253-9. PubMed ID: 10029561
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.
    Cote C, Pearle JL, Sharafkhaneh A, Spangenthal S.
    Pulm Pharmacol Ther; 2009 Feb 22; 22(1):44-9. PubMed ID: 19071226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.